Skip to main content

Table 3 Current status of minor indicators in the integration of oncology and palliative care programs in Japan

From: Current status of integrating oncology and palliative care in Japan: a nationwide survey

 

Designated Cancer Hospitals (n = 269)

Non-Designated Cancer Hospitals (n = 150)

P-value

Adjusted P-value

n (%)

n (%)

  

Clinical Process

 Institutionally accepted palliative care symptom management guidelines in written format

239 (88.9)

118 (78.7)

0.004

0.238

 Institutionally accepted palliative care referral criteria available in written format

193 (71.7)

88 (58.7)

< 0.001

0.077

 Available institutionally accepted clinical care pathways (automatic triggers) for palliative care referral

47 (17.8)

8 (5.3)

< 0.001

< 0.001

Palliative care team routinely involved in multidisciplinary tumor conference for patient case discussions

 Attending always

128 (47.6)

38 (25.3)

< 0.001

< 0.001

 Attending when necessary

104 (38.7)

42 (28.0)

  

 Not attending

32 (11.9)

22 (14.7)

  

 Multidisciplinary tumor conference is not held/no palliative care team

3 (1.1)

46 (30.7)

  

 Presence of palliative care specialists among cancer center senior leadership (e.g., head of oncology department/division and chief executives)

103 (38.3)

44 (29.3)

< 0.001

0.052

 Administration of systemic cancer therapy (e.g., chemotherapy and targeted agents) in palliative care patients possible

263 (97.8)

145 (96.7)

0.115

0.262

Availability of the same-day inpatient palliative care consultation upon request

 Almost all (≥90%)

192 (71.4)

69 (46.0)

< 0.001

< 0.001

 Mostly (50–89%)

60 (22.3)

41 (27.3)

  

 Less likely (< 49%)

14 (5.2)

28 (18.7)

  

 Not available

0 (0.0)

12 (8.0)

  

Availability of same-day outpatient palliative care consultation upon request

 Almost all (≥90%)

140 (52.0)

42 (28.0)

< 0.001

< 0.001

 Mostly (50–89%)

72 (26.8)

49 (32.7)

  

 Less likely (< 49%)

52 (19.3)

35 (23.3)

  

 Not available

2 (0.7)

23 (15.3)